Innoviva, Inc. is a company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited (“GSK”). Innoviva’s corporate structure and access to public markets allows for a creative and flexible approach to generating value for its stockholders. Innoviva has demonstrated its commitment to return value to shareholders through its capital return program.


Deerfield Management is an investment management firm committed to advancing healthcare through investment, information and philanthropy.

HealthCap is a European venture capital firm investing exclusively and globally in life sciences. The investment strategy focuses on diseases with high unmet medical needs and breakthrough therapies that have the potential to be transformative and change medical practice, and the lives of patients suffering these conditions. Having raised more than EUR 1 billion since 1996, HealthCap has backed and built more than 100 companies, taken more than 40 companies public and done numerous trade sales.

Morningside Ventures

Morningside Venture is a diversified investment group founded in 1986. It is engaged primarily in private equity and venture capital investments. The group has investments in North America, Europe, and Asia. Morningside is an active investor in early-stage companies founded around novel life science and medical technology.

Sofinnova Founded in 1974, Sofinnova specializes in clinical and late preclinical investments in biopharmaceutical products. Our goal is to actively partner with entrepreneurs across all stages of company development. We seek to build world-class companies that aspire to dramatically improve the current state of medical care and the lives of patients through bringing innovative products to market.

For more information about InCarda: